1/8
05:17 pm
cnmd
CONMED Corporation Announces Chief Financial Officer Transition [Yahoo! Finance]
Low
Report
CONMED Corporation Announces Chief Financial Officer Transition [Yahoo! Finance]
1/8
04:55 pm
cnmd
CONMED Corporation Announces Chief Financial Officer Transition
Low
Report
CONMED Corporation Announces Chief Financial Officer Transition
1/5
04:10 pm
cnmd
CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/5
04:05 pm
cnmd
CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026
Medium
Report
CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026
1/3
05:42 am
cnmd
CONMED (NYSE:CNMD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
CONMED (NYSE:CNMD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
12/8
08:13 am
cnmd
CONMED (NYSE:CNMD) had its price target lowered by analysts at Bank of America Corporation from $65.00 to $52.00. They now have a "neutral" rating on the stock.
Low
Report
CONMED (NYSE:CNMD) had its price target lowered by analysts at Bank of America Corporation from $65.00 to $52.00. They now have a "neutral" rating on the stock.
12/5
08:00 am
cnmd
CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines
Medium
Report
CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines
11/6
05:26 pm
cnmd
CONMED (NYSE:CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $58.00 to $52.00. They now have a "neutral" rating on the stock.
Low
Report
CONMED (NYSE:CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $58.00 to $52.00. They now have a "neutral" rating on the stock.
11/6
11:11 am
cnmd
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
Medium
Report
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
11/6
10:50 am
cnmd
CONMED (NYSE:CNMD) had its price target lowered by analysts at Wells Fargo & Company from $57.00 to $47.00. They now have an "equal weight" rating on the stock.
Medium
Report
CONMED (NYSE:CNMD) had its price target lowered by analysts at Wells Fargo & Company from $57.00 to $47.00. They now have an "equal weight" rating on the stock.
11/6
12:10 am
cnmd
Conmed Corp (CNMD) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amidst Margin Challenges [Yahoo! Finance]
Low
Report
Conmed Corp (CNMD) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amidst Margin Challenges [Yahoo! Finance]
11/5
04:05 pm
cnmd
CONMED Corporation Announces Third Quarter 2025 Financial Results
Medium
Report
CONMED Corporation Announces Third Quarter 2025 Financial Results